Cargando…
Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation
[Image: see text] Despite the enormous advancements in nanomedicine research, a limited number of nanoformulations are available on the market, and few have been translated to clinics. An easily scalable, sustainable, and cost-effective manufacturing strategy and long-term stability for storage are...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103128/ https://www.ncbi.nlm.nih.gov/pubmed/36976817 http://dx.doi.org/10.1021/acsami.2c21586 |
_version_ | 1785025816595267584 |
---|---|
author | Zhu, Geyunjian H. Azharuddin, Mohammad Pramanik, Bapan Roberg, Karin Biswas, Sujoy Kumar D’arcy, Padraig Lu, Meng Kaur, Apanpreet Chen, Alexander Dhara, Ashis Kumar Chivu, Alexandru Zhuang, Yunhui Baker, Andrew Liu, Xiewen Fairen-Jimenez, David Mazumder, Bismoy Chen, Rongjun Kaminski, Clemens F. Kaminski Schierle, Gabriele S. Hinkula, Jorma Slater, Nigel K. H. Patra, Hirak K. |
author_facet | Zhu, Geyunjian H. Azharuddin, Mohammad Pramanik, Bapan Roberg, Karin Biswas, Sujoy Kumar D’arcy, Padraig Lu, Meng Kaur, Apanpreet Chen, Alexander Dhara, Ashis Kumar Chivu, Alexandru Zhuang, Yunhui Baker, Andrew Liu, Xiewen Fairen-Jimenez, David Mazumder, Bismoy Chen, Rongjun Kaminski, Clemens F. Kaminski Schierle, Gabriele S. Hinkula, Jorma Slater, Nigel K. H. Patra, Hirak K. |
author_sort | Zhu, Geyunjian H. |
collection | PubMed |
description | [Image: see text] Despite the enormous advancements in nanomedicine research, a limited number of nanoformulations are available on the market, and few have been translated to clinics. An easily scalable, sustainable, and cost-effective manufacturing strategy and long-term stability for storage are crucial for successful translation. Here, we report a system and method to instantly formulate NF achieved with a nanoscale polyelectrolyte coacervate-like system, consisting of anionic pseudopeptide poly(l-lysine isophthalamide) derivatives, polyethylenimine, and doxorubicin (Dox) via simple “mix-and-go” addition of precursor solutions in seconds. The coacervate-like nanosystem shows enhanced intracellular delivery of Dox to patient-derived multidrug-resistant (MDR) cells in 3D tumor spheroids. The results demonstrate the feasibility of an instant drug formulation using a coacervate-like nanosystem. We envisage that this technique can be widely utilized in the nanomedicine field to bypass the special requirement of large-scale production and elongated shelf life of nanomaterials. |
format | Online Article Text |
id | pubmed-10103128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101031282023-04-15 Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation Zhu, Geyunjian H. Azharuddin, Mohammad Pramanik, Bapan Roberg, Karin Biswas, Sujoy Kumar D’arcy, Padraig Lu, Meng Kaur, Apanpreet Chen, Alexander Dhara, Ashis Kumar Chivu, Alexandru Zhuang, Yunhui Baker, Andrew Liu, Xiewen Fairen-Jimenez, David Mazumder, Bismoy Chen, Rongjun Kaminski, Clemens F. Kaminski Schierle, Gabriele S. Hinkula, Jorma Slater, Nigel K. H. Patra, Hirak K. ACS Appl Mater Interfaces [Image: see text] Despite the enormous advancements in nanomedicine research, a limited number of nanoformulations are available on the market, and few have been translated to clinics. An easily scalable, sustainable, and cost-effective manufacturing strategy and long-term stability for storage are crucial for successful translation. Here, we report a system and method to instantly formulate NF achieved with a nanoscale polyelectrolyte coacervate-like system, consisting of anionic pseudopeptide poly(l-lysine isophthalamide) derivatives, polyethylenimine, and doxorubicin (Dox) via simple “mix-and-go” addition of precursor solutions in seconds. The coacervate-like nanosystem shows enhanced intracellular delivery of Dox to patient-derived multidrug-resistant (MDR) cells in 3D tumor spheroids. The results demonstrate the feasibility of an instant drug formulation using a coacervate-like nanosystem. We envisage that this technique can be widely utilized in the nanomedicine field to bypass the special requirement of large-scale production and elongated shelf life of nanomaterials. American Chemical Society 2023-03-28 /pmc/articles/PMC10103128/ /pubmed/36976817 http://dx.doi.org/10.1021/acsami.2c21586 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Zhu, Geyunjian H. Azharuddin, Mohammad Pramanik, Bapan Roberg, Karin Biswas, Sujoy Kumar D’arcy, Padraig Lu, Meng Kaur, Apanpreet Chen, Alexander Dhara, Ashis Kumar Chivu, Alexandru Zhuang, Yunhui Baker, Andrew Liu, Xiewen Fairen-Jimenez, David Mazumder, Bismoy Chen, Rongjun Kaminski, Clemens F. Kaminski Schierle, Gabriele S. Hinkula, Jorma Slater, Nigel K. H. Patra, Hirak K. Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation |
title | Feasibility of Coacervate-Like
Nanostructure for Instant
Drug Nanoformulation |
title_full | Feasibility of Coacervate-Like
Nanostructure for Instant
Drug Nanoformulation |
title_fullStr | Feasibility of Coacervate-Like
Nanostructure for Instant
Drug Nanoformulation |
title_full_unstemmed | Feasibility of Coacervate-Like
Nanostructure for Instant
Drug Nanoformulation |
title_short | Feasibility of Coacervate-Like
Nanostructure for Instant
Drug Nanoformulation |
title_sort | feasibility of coacervate-like
nanostructure for instant
drug nanoformulation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103128/ https://www.ncbi.nlm.nih.gov/pubmed/36976817 http://dx.doi.org/10.1021/acsami.2c21586 |
work_keys_str_mv | AT zhugeyunjianh feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT azharuddinmohammad feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT pramanikbapan feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT robergkarin feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT biswassujoykumar feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT darcypadraig feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT lumeng feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT kaurapanpreet feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT chenalexander feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT dharaashiskumar feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT chivualexandru feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT zhuangyunhui feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT bakerandrew feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT liuxiewen feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT fairenjimenezdavid feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT mazumderbismoy feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT chenrongjun feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT kaminskiclemensf feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT kaminskischierlegabrieles feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT hinkulajorma feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT slaternigelkh feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation AT patrahirakk feasibilityofcoacervatelikenanostructureforinstantdrugnanoformulation |